BASF expects Force Majeure to end in Q3
Global ingredients supplier BASF says it expects to life its Force Majeure on human nutrition products including vitamin A, vitamin E and carotenoids from the middle of Q3 2018.
Archives for July 5, 2018
Gut bacteria changes may provide strong evidence for early-stage liver disease
Chemical by-products produced by gut bacteria could form the basis of a test to detect the early stages of liver disease, according to a European-based study published in Nature.
EPA metabolite preserves bone tissue in study
Researchers working with a metabolite of EPA have found that the compound plays a role in preserving bone tissue during an inflammatory challenge.
NDI filings coming in at expected rate, FDA says, but questions on GRAS process remain
The confused picture on New Dietary Ingredients became a bit clearer this week when FDA updated the public docket on filings and said it does not expect there to be a significant change in how many companies are choosing to go through the process.
Study supports collagen’s skin health benefits: RCT
Supplementation with a low molecular-weight collagen peptide may boost skin health from within by improving hydration and elasticity, says a new study from South Korea.
China's 'amazing industry growth' shows no sign of slowing...despite regulatory barriers
China's supplement market will continue to experience double-digit annual growth for the next couple of years, but longer-term success hinges on regulatory reform, says the executive director of Health Products Association – China.